DHG Pharmaceutical JSC 2016 SR
The report highlights DHG Pharma's performance in 2016, marking the first year of its 2016-2020 development strategy. The company maintained its leading position in Vietnam's pharmaceutical industry, achieving net revenue of VND 3,783 billion. Key milestones included a strategic partnership with Taisho Pharmaceutical and scientific cooperation with the Institute of Biotechnology. Sustainability efforts focused on human resource development, environmental protection through energy and water-saving initiatives, and extensive community health programs. The report also details the company's commitment to product quality, with 32 products achieving bioequivalence.
Company: DHG Pharmaceutical JSC
Sector: Manufacturing
Country: Vietnam
Year: 2016
Type: SR
Pages: 64
Back to company
DHG Pharmaceutical JSC
Sustainable Development Report
The report highlights DHG Pharma's performance in 2016, marking the first year of its 2016-2020 development strategy. The company maintained its leading position in Vietnam's pharmaceutical industry, achieving net revenue of VND 3,783 billion. Key milestones included a strategic partnership with Taisho Pharmaceutical and scientific cooperation with the Institute of Biotechnology. Sustainability efforts focused on human resource development, environmental protection through energy and water-saving initiatives, and extensive community health programs. The report also details the company's commitment to product quality, with 32 products achieving bioequivalence.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2016
Reporting Period
Jan 1, 2016 - Dec 31, 2016
Fiscal Year
2016
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Water Consumption
Women in Management
Workplace Fatalities
Employees